Market Research Logo

Endologix Inc (ELGX) - Product Pipeline Analysis, 2018 Update

Summary

Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). The company’s AAA products are built on traditional minimally-invasive endovascular repair (EVAR) platform or endovascular sealing (EVAS) platform. The company’s EVAR products include AFX endovascular AAA system Vela Proximal Endograft and Intuitrak endovascular AAA system; and EVAS products comprise Nellix endovascular aneurysm sealing system. It has manufacturing facility in Irvine. The company sells its products to hospitals in the US and Europe through direct sales force and through third-party international distributors and agents in other parts of the world. Endologix is headquartered in California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Endologix Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Endologix Inc Company Overview
Endologix Inc Company Snapshot
Endologix Inc Pipeline Products and Ongoing Clinical Trials Overview
Endologix Inc – Pipeline Analysis Overview
Business Description
Endologix Inc - Key Facts
Endologix Inc - Major Products and Services
Endologix Inc Pipeline Products by Development Stage
Endologix Inc Ongoing Clinical Trials by Trial Status
Endologix Inc Pipeline Products Overview
AFX2 Bifurcated Endograft System
AFX2 Bifurcated Endograft System Product Overview
AFX3
AFX3 Product Overview
AFX4
AFX4 Product Overview
Nellix CHEVAS
Nellix CHEVAS Product Overview
Nellix EVAS System
Nellix EVAS System Product Overview
Nellix EVAS System Clinical Trial
Nellix With Snorkels
Nellix With Snorkels Product Overview
Nellix2 AAA Endovascular System
Nellix2 AAA Endovascular System Product Overview
Nellix2 AAA Endovascular System Clinical Trial
Ovation Alto Abdominal Stent Graft System
Ovation Alto Abdominal Stent Graft System Product Overview
Ovation Alto Abdominal Stent Graft System Clinical Trial
Ovation Alto System
Ovation Alto System Product Overview
Ovation IX Abdominal Stent Graft System
Ovation IX Abdominal Stent Graft System Product Overview
Ovation IX Abdominal Stent Graft System Clinical Trial
Ovation Thoracic Stent Graft System
Ovation Thoracic Stent Graft System Product Overview
Paravisceral System
Paravisceral System Product Overview
Ventana 2
Ventana 2 Product Overview
Xpand BX Covered Stent
Xpand BX Covered Stent Product Overview
Xpand BX Covered Stent Clinical Trial
Endologix Inc - Key Competitors
Endologix Inc - Key Employees
Endologix Inc - Key Employee Biographies
Endologix Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Endologix Inc, Recent Developments
May 02, 2018: Endologix Names John Onopchenko As Chief Executive Officer
May 02, 2018: Endologix Announces First Quarter 2018 Financial Results
Apr 25, 2018: Endovascular Aneurysm Sealing (EVAS) with Nellix System Associated with Higher Survival than Traditional Endovascular Aneurysm Repair (EVAR) in New Study
Mar 19, 2018: Endologix Reports Positive Results from Global ENCORE Analysis with Polymer Endovascular Aneurysm Repair (EVAR) Using Ovation Abdominal Stent Graft Systems
Mar 05, 2018: Endologix Announces Enrollment of the First Patient in EVAS2 IDE Clinical Study of the Nellix EndoVascular Aneurysm Sealing System
Feb 21, 2018: Endologix Announces Resignation Of John McDermott As Chief Executive Officer
Feb 21, 2018: Endologix Reports Fourth Quarter and Fiscal Year 2017 Financial Results
Feb 05, 2018: Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
Feb 05, 2018: Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
Jan 29, 2018: Endologix Appoints Greg Morrow as Chief Marketing Officer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Endologix Inc Pipeline Products and Ongoing Clinical Trials Overview
Endologix Inc Pipeline Products by Equipment Type
Endologix Inc Pipeline Products by Indication
Endologix Inc Ongoing Clinical Trials by Trial Status
Endologix Inc, Key Facts
Endologix Inc, Major Products and Services
Endologix Inc Number of Pipeline Products by Development Stage
Endologix Inc Pipeline Products Summary by Development Stage
Endologix Inc Ongoing Clinical Trials by Trial Status
Endologix Inc Ongoing Clinical Trials Summary
AFX2 Bifurcated Endograft System - Product Status
AFX2 Bifurcated Endograft System - Product Description
AFX3 - Product Status
AFX3 - Product Description
AFX4 - Product Status
AFX4 - Product Description
Nellix CHEVAS - Product Status
Nellix CHEVAS - Product Description
Nellix EVAS System - Product Status
Nellix EVAS System - Product Description
Nellix EVAS System - Multicenter, Observational, Registry to Assess Outcomes of Patients Treated With the CE Marked Nellix System for Endovascular Abdominal Aortic Aneurysm Repair
Nellix EVAS System - Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study: EVAS 2 Confirmatory IDE Study
Nellix EVAS System - Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System: A Pivotal and Continued Access Study
Nellix EVAS System - Study of a Sealing Type Stent-graft For Abdominal Aortic Aneurysm
Nellix With Snorkels - Product Status
Nellix With Snorkels - Product Description
Nellix2 AAA Endovascular System - Product Status
Nellix2 AAA Endovascular System - Product Description
Nellix2 AAA Endovascular System - Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study: EVAS 2 Confirmatory IDE Study
Ovation Alto Abdominal Stent Graft System - Product Status
Ovation Alto Abdominal Stent Graft System - Product Description
Ovation Alto Abdominal Stent Graft System - Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft IDE Study
Ovation Alto System - Product Status
Ovation Alto System - Product Description
Ovation IX Abdominal Stent Graft System - Product Status
Ovation IX Abdominal Stent Graft System - Product Description
Ovation IX Abdominal Stent Graft System - TriVascular Evaluation of Females Who are Underrepresented Candidates for Abdominal Aortic Aneurysm Repair: The LUCY Study
Ovation Thoracic Stent Graft System - Product Status
Ovation Thoracic Stent Graft System - Product Description
Paravisceral System - Product Status
Paravisceral System - Product Description
Ventana 2 - Product Status
Ventana 2 - Product Description
Xpand BX Covered Stent - Product Status
Xpand BX Covered Stent - Product Description
Xpand BX Covered Stent - Prospective, Multicenter, Single Arm Feasibility and Safety Study of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms
Endologix Inc, Key Employees
Endologix Inc, Key Employee Biographies
Endologix Inc, Subsidiaries
Glossary
List of Figures
Endologix Inc Pipeline Products by Equipment Type
Endologix Inc Pipeline Products by Development Stage
Endologix Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report